Viruses in type 1 diabetes

Pediatric Diabetes

Volumn 17, Issue , 2016, Pages 56-64

  Hyöty, Heikki ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

enterovirus; prevention; prospective studies; type 1 diabetes; virus infections

Indexed keywords

VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE;

AUTOIMMUNITY; CELL DAMAGE; DISEASE ASSOCIATION; ENTEROVIRUS B; ENTEROVIRUS INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 84978381249     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12370     Document Type: Review

References (64)

1. Knip M. Pathogenesis of type 1 diabetes: implications for incidence trends. Horm Res Paediatr 2011: 76 (Suppl 1): 57–64.
2. Hermann R, Knip M, Veijola R et al. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes--indication of an increased environmental pressure? Diabetologia 2003: 46: 420–425.
3. Kondrashova A, Seiskari T, Ilonen J, Knip M, Hyöty H. The 'Hygiene hypothesis' and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS 2013: 121: 478–493.
4. Yoon JW, Jun HS. Viruses cause type 1 diabetes in animals. Ann NY Acad Sci 2006: 1079: 138–146.
5. Morgan NG, Richardson SJ. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause? Trends Endocrinol Metab 2014: 25: 611–619.
6. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br Med J 2011: 342: d35.
7. Chapman NM, Kim KS. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr Top Microbiol Immunol 2008: 323: 275–292.
8. Tracy S, Smithee S, Alhazmi A, Chapman N. Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences. J Med Virol 2015: 87: 240–247.
9. Gamble DR, Taylor KW. Seasonal incidence of diabetes mellitus. Br Med J 1969: 3: 631–633.
10. Gamble DR, Kinsley ML, FitzGerald MG, Bolton R, Taylor KW. Viral antibodies in diabetes mellitus. Br Med J 1969: 3: 627–630.
11. Nurminen N, Oikarinen S, Hyöty H. Virus infections as potential targets of preventive treatments for type 1 diabetes. Rev Diabet Stud 2012: 9: 260–271.
12. Ylipaasto P, Klingel K, Lindberg AM et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004: 47: 225–239.
13. Jenson AB, Rosenberg HS, Notkins AL. Pancreatic islet-cell damage in children with fatal viral infections. Lancet 1980: 2: 354–358.
14. Krogvold L, Edwin B, Buanes T et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 2015: 64: 1682–1687.
15. Hyöty H, Hiltunen M, Knip M et al. A prospective study of the role of Coxsackie B and other enteroviruses in the pathogenesis of IDDM. Diabetes 1995: 44: 652–657.
16. Lönnrot M, Korpela K, Knip M et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth-cohort - The Finnish Diabetes Prediction and Prevention (DIPP) study. Diabetes 2000: 49: 1314–1318.
17. Juhela S, Hyöty H, Lönnrot M, Roivainen M, Simell O, Ilonen J. Enterovirus infections and enterovirus specific T-cell responses in infancy. J Med Virol 1998: 54: 226–232.
18. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008: 371: 1777–1782.
19. Sadeharju K, Lönnrot M, Kimpimäki T et al. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody -positive children. Diabetologia 2001: 44: 818–823.
20. Salminen K, Sadeharju K, Lönnrot M et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 2003: 69: 91–98.
21. Salminen KK, Vuorinen T, Oikarinen S et al. Isolation of enterovirus strains from children with preclinical type 1 diabetes. Diabet Med 2004: 21: 156–164.
22. Mäkelä M, Vaarala O, Hermann R et al. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J Autoimmun 2006: 27: 54–61.
23. Oikarinen S, Martiskainen M, Tauriainen S et al. Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 2011: 60: 276–279.
24. Lempainen J, Tauriainen S, Vaarala O et al. Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev 2012: 28: 177–185.
25. Laitinen OH, Honkanen H, Pakkanen O et al. Coxsackievirus B1 is associated with the induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 2014: 63: 446–455.
26. Ilonen J, Hammais A, Laine AP et al. Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 2013: 62: 3636–3640.
27. Kimpimäki T, Kupila A, Hämäläinen AM et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab 2001: 86: 4782–4788.
28. Viskari H, Knip M, Tauriainen S et al. Maternal enterovirus infection as a risk factor for type 1 diabetes in the exposed offspring. Diabetes Care 2012: 35: 1328–1332.
29. Hiltunen M, Hyöty H, Karjalainen J et al. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM - a prospective study. Diabetologia 1995: 38: 705–710.
30. Hyöty H, Räsänen L, Hiltunen M, Lehtinen M, Huupponen T, Leinikki P. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus. APMIS 1991: 99: 359–363.
31. Hyöty H, Hiltunen M, Reunanen A et al. Decline of mumps antibody levels in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after the introduction of mumps-measles-rubella vaccine in Finland. Diabetologia 1993: 36: 1303–1308.
32. Kramná L, Kolářová K, Oikarinen S et al. Gut virome sequencing in children with early islet autoimmunity. Diabetes Care 2015: 38: 930–933.
33. Oikarinen S, Tauriainen S, Hober D et al. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes 2014: 63: 655–662.
34. D'Alessio DJ. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 1992: 135: 1331–1338.
35. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979: 300: 1173–1179.
36. Dotta F, Censini S, van Halteren AG et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007: 104: 5115–5120.
37. Viskari H, Koskela P, Lönnrot M et al. Can changing epidemiology of enterovirus infections explain the increasing incidence of type 1 diabetes. Diabetes Care 2000: 23: 414–416.
38. Viskari H, Salur L, Uibo R et al. Correlations between the incidence of type 1 diabetes and enterovirus infections in Europe. J Med Virol 2004: 72: 610–617.
39. Viskari H, Ludvigsson J, Uibo R et al. Relationship between maternal enterovirus antibodies and type 1 diabetes – time-trends and geographical variation. Diabetologia 2005: 48: 1280–1287.
40. Nathanson N, Kew OM. From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol 2010: 172: 1213–1229.
41. Flodström M, Tsai D, Fine C, Maday A, Sarvetnick N. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes 2003: 52: 2025–2034.
42. Drescher KM, von Herrath M, Tracy S. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine. Rev Med Virol 2015: 25: 19–32.
43. Stene LC, Oikarinen S, Hyöty H et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010: 59: 3174–3180.
44. Williams CH, Oikarinen S, Tauriainen S, Salminen K, Hyöty H, Stanway G. Molecular analysis of an echovirus 3 strain isolated from an individual concurrent with the appearance of islet-cell and Ia-2 autoantibodies. J Clin Microbiol 2006: 44: 441–448.
45. Anagandula M, Richardson SJ, Oberste MS et al. Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway. J Med Virol 2014: 86: 1402–1411.
46. Hämäläinen S, Nurminen N, Ahlfors H et al. Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity. J Med Virol 2014: 86: 1412–1420.
47. Kallionpää H, Elo LL, Laajala E et al. Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility. Diabetes 2014: 63: 2402–2414.
48. Moulder R, Bhosale S, Erkkilä T et al. Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility. Diabetes 2015: 64: 2265–2278.
49. Koho T, Koivunen MLR, Oikarinen S et al. Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice. Antiviral Res 2014: 104: 93–101.
50. Larsson PG, Lakshmikanth T, Laitinen OH et al. A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development. Diabetologia 2015: 58: 346–354.
51. Hiltunen M, Hyöty H, Knip M et al. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. J Infect Dis 1997: 175: 554–560.
52. Sadeharju K, Hämäläinen A-M, Knip M et al. Enterovirus infections as a risk factor for type 1 diabetes – virus analyses in a dietary intervention trial. Clin Exp Immunol 2003: 132: 271–277.
53. Cinek O, Stene LC, Kramna L et al. Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with high genetic risk of type 1 diabetes. The MIDIA study. Diabetologia 2014: 57: 2193–2200.
54. Tauriainen S, Martiskainen M, Oikarinen S et al. Human parechovirus 1 infections in young children - no association with type 1 diabetes. J Med Virol 2007: 79: 457–462.
55. Kolehmainen P, Koskiniemi M, Oikarinen S et al. Human parechovirus and the risk for type 1 diabetes. J Med Virol 2013: 58: 211–215.
56. Honkanen H, Oikarinen S, Peltonen P et al. Human rhinoviruses including group C are common in stool samples of young Finnish children. J Clin Virol 2013: 56: 250–254.
57. Kondrashova A, Nurminen N, Patrikainen M et al. Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes. Diabetologia 2015: 58: 2592–2595.
58. Gamble DR, Taylor KW, Cumming H. Coxsackie viruses and diabetes mellitus. Br Med J 1973: 4: 260–262.
59. Gamble DR, Taylor KW. Coxsackie B virus and diabetes. Br Med J 1973: 1: 289–290.
60. Alberti AM, Amato C, Candela A et al. Serum antibodies against Coxsackie B1-6 viruses in type 1 diabetics. Acta Diabetol Lat 1985: 22: 33–38.
61. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009: 52: 1143–1151.
62. Bissel SJ, Winkler CC, DelTondo J, Wang G, Williams K, Wiley CA. Coxsackievirus B4 myocarditis and meningoencephalitis in newborn twins. Neuropathology 2014: 34: 429–437.
63. Muehlenbachs A, Bhatnagar J, Zaki SR. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol 2015: 235: 217–228.
64. Oikarinen M, Tauriainen S, Honkanen T et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008: 51: 1796–1802.